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Abstracts 
 
 
Background: Serine proteases have important roles in skin barrier function and 
desquamation, and the aberrant expression or the dysfunction of serine proteases is 
associated with the pathogenesis of skin diseases. Serine protease activities are tightly 
regulated by serine proteases such as kallikrein-related peptidases (KLKs) and serine 
protease inhibitors such as lympho-epithelial Kazal-type related inhibitor (LEKTI). For 
a better understating of diseases' pathogenesis, the regulation mechanism of serine 
proteases and the inhibitors' expression in epidermal keratinocytes must be clarified. 
Objectives: To investigate the effects of the cytokines on the expression of LEKTI in 
epidermal keratinocytes.  
Methods: Normal human epidermal keratinocytes (NHEKs) were stimulated with 
panels of inflammatory cytokines. The expression of serine protease inhibitors was 
analyzed using quantitative real-time PCR and ELISA. LEKTI expression in normal 
human skin and lesions from psoriasis or atopic dermatitis (AD) were analyzed by 
immunohistochemically and tape-stripping. Trypsin- and chymotrypsin-like serine 
protease activities in culture supernatants were measured by using specific substrates.  
Results: TNF-α and IL-17A significantly induced the expression of LEKTI in NHEKs. 
The immunohistochemical and tape-stripping analysis revealed that psoriatic skin 
lesions had higher LEKTI expression compared to normal skin and AD lesions. Trypsin- 
and chymotrypsin-like protease activities in the culture media were upregulated 3-5 
days later but attenuated 6-7 days later period by these cytokines.  
Conclusions: In epidermal keratinocytes, the Th1&Th17 cytokines TNF-α and IL-17A 
induce the expression of serine protease inhibitor LEKTI, and it might occur to suppress 
the increase in the serine protease activities under inflammation. 
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